PEP-Therapy, Institut Curie and Gustave Roussy join together to conduct the Clever-Peptide project.
It aims at the development of an innovative anti-cancer peptide, firstly for the treatment of triple-negative breast cancer, and its companion biomarker, predictive of treatment efficacy. Approved by the Medicen Paris Region cluster, this collaborative project obtains 2,9 M€ funding.